Vitamin D levels in Rheumatoid Arthritis and their co-relation with disease severity
Not Applicable
- Conditions
- Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified
- Registration Number
- CTRI/2019/02/017771
- Lead Sponsor
- KMC Manipal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All patients above 18 years of age of both sexes who give informed consent.
2. Proven cases of Rheumatoid arthritis as aided by the 2010 EULAR criteria.
Exclusion Criteria
1. Subjects receiving: Vitamin D, calcium, calcitonin, bisphosphonate, oestrogen supplementation, anti-epileptic drugs, thyroxine, steroids in the last 6 months.
2. Subjects having known pathologies interfering with calcium metabolism such as hyperparathyroidism or hypoparathyroidism.
3. Renal failure patients.
4. Patients with known granulomatous diseases like sarcoidosis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vitamin D levels in a very large number of cases of Rheumatoid Arthritis is expected to be deficient.Timepoint: End of trial period
- Secondary Outcome Measures
Name Time Method As severity of RA increases, the vitamin D levels should show an inverse decrease.Timepoint: End of study period (September 2020)